| Ticker Details |
Repligen Corporation
Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.
|
| IPO Date: |
March 26, 1990 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$6.76B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.22 | 2.14%
|
| Avg Daily Range (30 D): |
$2.29 | 1.92%
|
| Avg Daily Range (90 D): |
$2.34 | 1.67%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.3M |
| Avg Daily Volume (30 D): |
.71M |
| Avg Daily Volume (90 D): |
.62M |
| Trade Size |
| Avg Trade Size (Sh.): |
68 |
| Avg Trade Size (Sh.) (30 D): |
45 |
| Avg Trade Size (Sh.) (90 D): |
43 |
| Institutional Trades |
| Total Institutional Trades: |
6,079 |
| Avg Institutional Trade: |
$5.14M |
| Avg Institutional Trade (30 D): |
$6.8M |
| Avg Institutional Trade (90 D): |
$8.13M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$7.48M |
| Avg Closing Trade (30 D): |
$13.3M |
| Avg Closing Trade (90 D): |
$13.67M |
| Avg Closing Volume: |
62.98K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$.87
|
$.24
|
$.87
|
|
Diluted EPS
|
$.86
|
$.23
|
$.86
|
|
Revenue
|
$738.26M
|
$197.91M
|
$738.26M
|
|
Gross Profit
|
$386.25M
|
$103.83M
|
$386.25M
|
|
Net Income / Loss
|
$48.89M
|
$13.29M
|
$48.89M
|
|
Operating Income / Loss
|
$55.17M
|
$17.87M
|
$55.17M
|
|
Cost of Revenue
|
$352.01M
|
$94.08M
|
$352.01M
|
|
Net Cash Flow
|
$-196.26M
|
$-182.85M
|
$-196.26M
|
|
PE Ratio
|
139.65
|
|
|
|
|
|
